Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The myelin sheath synthesis pathway comprises the complex series of cellular, metabolic, and molecular events that lead to the generation of myelin sheaths—the multi-lamellar, lipid-rich structures that insulate axons in the central and peripheral nervous systems. Key steps include the expression and post-translational modification of myelin proteins (such as myelin basic protein and proteolipid protein)[1][2], the synthesis and trafficking of specific lipids[2], and the coordinated assembly of these components into compact myelin membranes by oligodendrocytes (central nervous system) or Schwann cells (peripheral nervous system)[2]. This process is critical for the efficient conduction of nerve impulses and is dysregulated in a variety of demyelinating diseases such as multiple sclerosis and leukodystrophies. The pathway itself is not a druggable target but contains many druggable components (enzymes, signaling proteins, etc.) whose manipulation may impact myelination[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myelin sheath synthesis pathway.